Cargando…
P488 Successful treatment of breakthrough invasive aspergillosis in an immunocompetent individual based on therapeutic drug monitoring: A case report
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: BACKGROUND: Invasive aspergillosis (IA) is an opportunistic fungal infection in immunocompromised patients with high mortality. Aspergillus flavus is the second pathogen of IA. Breakthrough IA was defined as any IA occurring during exposure...
Autores principales: | Yin, Xin, Zong, Zhiyong, Liu, Yanbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509947/ http://dx.doi.org/10.1093/mmy/myac072.P488 |
Ejemplares similares
-
P248 Fungal meningitis in an immunocompetent individual
por: Ningthoujam, Priyolakshmi, et al.
Publicado: (2022) -
P460 The Aspergillus Lateral Flow Assay for the diagnosis of invasive Aspergillosis
por: Liu, Chonglong, et al.
Publicado: (2022) -
P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022) -
Invasive aspergillosis in an immunocompetent host
por: Sethi, Preeti, et al.
Publicado: (2012) -
P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)